This site is intended for healthcare professionals only
LoginRegister
Moderna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID riskModerna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID risk
Merck Animal Health gets USFDA nod for Bravecto Quantum to protect dogs from fleas, ticksMerck Animal Health gets USFDA nod for Bravecto Quantum to protect dogs from fleas, ticks
Pfizer Gets CDSCO Panel Nod To Conduct Phase III Trial of RSV Vaccine in India, Told to Clarify Subject CriteriaPfizer Gets CDSCO Panel Nod To Conduct Phase III Trial of RSV Vaccine in India, Told to Clarify...
Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancerBayer seeks EMA nod for Gadoquatrane
Violation of Nursing Home Registration Act: Maharashtra cancels Licenses of 258 Private Hospitals4 Pharma Firms Lose Licenses Over Pregabalin, Tapentadol Misuse
Veeda Clinical Research Gets Expert Committee Nod To Conduct BA/BE Study Of Ibrutinib For ExportUnreadable Expiry Dates, Generic Mix-Ups: Govt Panel Proposes Forming Sub-Committee on Medicine...
Girl With Fever Given Rabies Vaccine, Probe OrderedSEC Flags Safety, Efficacy Gaps in Troikaa's Rapid IV Paracetamol Bolus Proposal, Seeks More Data
Panacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant LibraryPanacea Biotec, Apotex resolve dispute over breach of collaboration agreement
Delay implementation of ONDLS-only COPP submission model: Pharmexcil requests CDSCO, Health MinistryDelay implementation of ONDLS-only COPP submission model: Pharmexcil requests CDSCO, Health Ministry
Racket manufacturing fake medicines busted, factory owner heldOver 5300 bottles of fake cough syrup seized, 1 arrested
Novartis loses legal battle to block US Entresto generic until 2026Novartis loses legal battle to block US Entresto generic until 2026
Wockhardt to exit US generic pharmaceutical segmentWockhardt to exit US generic pharmaceutical segment
X